Report post
Jim Lebenthal, a financial expert, has increased his investment in Abbvie, a pharmaceutical company. Abbvie's stock price has risen by 11% this year, indicating a positive market performance. The mention of investing $10,000 into Abbvie suggests a potential buying opportunity. The content hints at a bullish outlook on Abbvie's future, with Lebenthal's additional purchase serving as a possible indicator of his confidence in the company's growth potential.

The World's Leading Crypto Trading Platform

Get my welcome gifts